Literature DB >> 33189569

Therapeutic leukapheresis and thrombapheresis in medical emergencies.

Christian Coffe1, Fabienne Pouthier2, Christophe Barisien3, Mohamed Slimane4, Antoaneta Sheytanova5.   

Abstract

The management of hyperleukocytosis or thrombocytosis by therapeutic cytapheresis in the early 21 st century is far from codified (universal). Therapeutic cytapheresis have been proposed to achieve more rapid cytoreduction in peripheral blood than old universal support in order to quickly prevent potential complications. But, there are no randomized studies demonstrating the superiority of cytapheresis over other treatments alone. In this short review, based on our own experience (since 1980), we will give the indications and the role of cytapheresis procedures and we will try to answer the questions: when is therapeutic cytapheresis appropriate and do they still have a place in 2020, especially as a medical emergency?
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytapheresis; Hyperleukocytosis; Leukapheresis; Thrombapheresis; Thrombocytosis

Mesh:

Year:  2020        PMID: 33189569     DOI: 10.1016/j.transci.2020.102997

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  1 in total

1.  Therapeutic Leukapheresis: Experience of a Single Oncologic Centre.

Authors:  Maria Rosales; Susana Roncon; Mário Mariz; Ana Maia Ferreira; Filomena Faria; Luisa Santos
Journal:  Transfus Med Hemother       Date:  2022-02-01       Impact factor: 4.040

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.